Assuring research compliance  with laws, regulations and Howard University policies.  

Office of Regulatory Research Compliance
Howard University
Howard University Research Building 1
1840 7th Street, NW
Suite 309
Washington, D.C. 20001
(202) 865-8597 
Office of Regulatory  Research Compliance 

Howard University
HU Research Bldg 1
1840 7th Street, NW
Suite 309
Washington, D.C. 20001

Phone: (202) 865-8597
Fax:     (202) 232-5286

ORRC is located directly across  from the Howard University  Shaw Metro  on 7th Seventh St.(Georgia Ave) on the third floor       of  the Howard University    Research Building-1.

Office of Regulatory Research Compliance
Welcome to the Office of Regulatory Research Compliance website!
Is it Research?
Involve Human Subject?
Qualify for Exempt?
Qualify for Expedited?
Other Resources
Case Report

                                          MISSION STATEMENT
                                       IMPORTANT INFORMATION


Given the recent re-organization in the Office of Regulatory Research Compliance, we advise that all correspondence to the IRB should be directed as follows: 

  For Medical IRB: Dr. Evaristus Nwulia (Chair of the Medical IRB) 

  For Non-Medical IRB: Dr. Alfonso Campbell (Chair of the Non-Medical IRB)

Please, note that the IRB Chairs are acting on behalf of the Howard University Human Subject Compliance Program. Therefore, we emphasize that all IRB and protocol -related communications to the Chairs, be channeled through the following email addresses: 

  Medical IRB:
  Non-Medical ORRC:

To read more, click the pdf file. 
In an effort to better streamline the Health Insurance Portability and Accountability Act (HIPAA) training procedures, the Office of Regulatory Research Compliance (ORRC) and the Institutional Compliance Office have reached the following agreement. Henceforth, Clinician Scientists and Research Staff should only complete the Clinician Scientist module of the Collaborative Institutional Training Initiatives (CITI). A certificate of successful completion of this module is considered sufficient to meet the HIPAA training requirements of the ORRC and the Institutional Compliance Office. The certification is good for 2 years.

To read more, click the pdf file.  

To better track and streamline the processing of research and other applications, the Office of Regulatory Research Compliance (ORRC) will begin accepting these submissions via newly designated e-mail addresses. This new process becomes effective September 11, 2017. Details are enumerated below.

• -- Medical-IRB (Medical Institutional Review Board): For review of "Human Subjects Research" involving the study of specific diseases and conditions (mental or physical), including detection, cause, treatment and rehabilitation of persons; the design of methods, drugs and devices used to diagnose, support and maintain the individual during and after treatment for specific diseases or conditions; and/or scientific investigation.

•  -- Non-Medical IRB (Non-Medical Institutional Review Board): For review of research that deals with human attitudes, beliefs, and behaviors and is often characterized by data collection methods such as questionnaires, interviews, focus groups, direct or participant observation, and non-invasive physical measurements (qualitative or quantitative).

• -- IACUC (Institutional Animal Care and Use Committee): For review of research involving animals.

•  -- IBC (Institutional Biosafety Committee): For review of research utilizing recombinant DNA or synthetic nucleic acid molecules, viral vectors, plasmid vectors, or other infectious agents, genetically modified plants or biohazardous materials (i.e. blood, human tissue, etc.)

• - (Excluded Research): For review of studies and or projects that do not involve the use of human participants or human data, biohazardous materials, animals.

• -- MTA (Material Transfer Agreement): For reviews, involving the transfer of incoming or outgoing biohazardous materials and data.

• -- For general communications or to report compliance issues/concerns

• -- COI (Conflict of Interest)

When submitting materials/applications, each e-mail should include items for only one study. For example, the e-mail may contain the protocol, consent document, and investigator brochure for one study.

• Submit only complete, fully-signed documents. An e-mail acknowledgement in place of a signed application will not be accepted. If electronic signatures are not available, the signature pages may be signed and scanned as a separate PDF document and attached to your submission e-mail. 

• Unless requested, please do not submit additional study related information until the protocol has been approved.

When submitting your materials to the IRB, IACUC, or IBC:

• The e-mail subject line must include:

  o Protocol # (if assigned)

  o Principal Investigator's last name

  o The type of submission (new project, amendment, renewal, protocol  

  deviation, serious adverse events, etc.)

• The body of your e-mail must include a list of the documents being submitted, and each document's name should reflect its content.

• We recommend that version dates are included in each document naming nomenclature.

• Incomplete applications (i.e. missing required supporting document) would be returned.

The U.S. Department of Health and Human Services and fifteen other Federal Departments and Agencies have announced proposed revisions to modernize, strengthen, and make more effective the Federal Policy for the Protection of Human Subjects that was promulgated as a Common Rule in 1991. The Notice of Proposed Rulemaking (NPRM) was published in the Federal Register on September 8, 2015 by the Office of the Federal Register. The NPRM, which can be accessed at the following URL:, seeks comment on proposals to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. The new comment period deadline is January 6, 2015. These departments and agencies are committed to affording the public a meaningful opportunity to comment on the NPRM and welcome comments.  Read more
Introducing The Institutional Review Board (IRB) Leadership
Clinician Scientists - Harmonization of HIPAA Training Requirements 
HHS Proposes Significant Changes to the Federal Policy for the Protection of Human Subjects ("Common Rule")
The Office of Regulatory Research Compliance (ORRC) will close during the Spring Break

The Office of Regulatory Research Compliance (ORRC) will be closed beginning Friday, March 13, 2020 at 5:00pm. The office will reopen on Monday, March 23, 2020. In preparation for the break, please note the following information: 

The break does not alter the Institutional Animal Care and Use Committee (IACUC); Institutional Biosafety Committee (IBC); or Institutional Review Board (IRB) meeting schedules or deadlines for submission. During the spring break, Investigators may submit completed and signed applications for review via email to: 

                            Medical IRB -
                    Non-Medical IRB -
                    IACUC -
                    IBC -
                    Excluded Research -
                    General Communication -
                    MTA -

Review of applications will not occur during this period, but they will be processed for review after the ORRC reopens on March 23, 2020. 

Please note: Email is the preferred method of communication during the break.

Please click here

Please Read

National Institute of Health (3/17/20)

National Science Foundation (3/17/20) 

Office of Justice Programs, DOJ (Guidance sent to Grantees, Subject to Change)

National Security Agency (Guidance sent to Contractors, Subject to Change) 

Department of Energy (3/13/20) 

National Aeronautics and Space Administration (3/10/20) 

USDA - National Institute of Food and Agriculture 

United States Army Medical Research Acquisition Activity 

Food and Drug Administration 

Department of Health and Human Services (3/14/20) 

Department of Air Force (Sent to Contractors, Subject to Change)